5 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186Shao, S., Scholtz, L.-U., Gendreizig, S., Martínez-Ruiz, L., Florido, J., Escames, G., Schürmann, M., Hain, C., Hose, L., Mentz, A., Schmidt, P., Wang, M., Goon, P., Wehmeier, M., Brasch, F., Kalinowski, J., Oppel, F., Sudhoff, H.: Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes. BMC Cancer. 23, : 47 (2023).PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718Oppel, F., Shao, S., Gendreizig, S., Kühnel, P., Przybycin, V., Hain, C., Schmidt, P., Schürmann, M., Goon, P., Niehaus, K., Kalinowski, J., Sudhoff, H.: Head and neck cancer cells can differentiate and resemble their tissue of origin. Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA. Cancer Research. 82, p. 111-111. American Association for Cancer Research (AACR) (2022).PUB | DOI | WoS
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816Gendreizig, S., Neumann, J.M., Loganathan, L., Hose, L., Goon, P., Oppel, F., Brasch, F., Niehaus, K., Sudhoff, H.: P35 Spatial proteomics and metabolomics investigations in head & neck cancers. Oral Oncology. 134, : 106164 (2022).PUB | DOI | WoS
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817Oppel, F., Gendreizig, S., Kühnel, P., Martínez-Ruiz, L., Shao, S., Schmidt, P., Hain, C., Schürmann, M., Hose, L., Pabla, H., Loganathan, L., Viyof Ful, F., Przybycin, V., Scholtz, L.-U., Brasch, F., Busche, T., Goon, P., Escames, G., Niehaus, K., Kalinowski, J., Sudhoff, H.: P28 Head and neck cancer cells differentiate resembling their tissue of origin. In: Amsterdam University Medical Centers (ed.) Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management. Oral Oncology. 134, Elsevier (2022).PUB | DOI | WoS
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703Oppel, F., Shao, S., Gendreizig, S., Zimmerman, M.W., Schürmann, M., Viyof Ful, F., Goon, P., Chi, S.N., Aster, J.C., Sudhoff, H., Look, A.T.: p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition. Molecular Cancer Therapeutics. (2022).PUB | DOI | WoS | PubMed | Europe PMC